Sign in
Taking people in United StatesNo phase

Noninvasive Vagal Nerve Stimulation and Cognitive Rehabilitation

Key facts

Who runs it
Shirley Ryan AbilityLab
Where
Chicago, United StatesSee the site
Trial code
Status
Recruiting
People taking part
60 people, planned
Started
7 Sept 2024
Planned end
Aug 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Transcutaneous auricular vagus active nerve stimulation
  • Transcutaneous auricular vagus sham nerve stimulation
Record updated
25 March 2025

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • In inpatient rehabilitation due to recent Traumatic Brain Injury, ages 18-65 years
  • Ability to independently use a keyboard. Able to understand and communicate in English (according to clinical judgment). Able to independently provide consent to participate. Orientation to place, time, and situation (two consecutive scores of 25 or more on the Orientation Log(O-Log)40. This scale is routinely administered during acute rehabilitation stay

Who cannot take part

  • Acute medical issues requiring close physician or nursing monitoring. Bioelectrical implants, including pacemakers. Pregnancy or persons who are lactating. Significant gross or fine motor weakness. Significant, ongoing communication or comprehension impairments (such as aphasia) that would affect an individual's ability to complete the required assessments
  • Acute agitation or behavioral issues, as defined by a last Agitated Behavior Scale Score greater than 21 (routinely administered during acute rehabilitation stay, that would affect an individual's ability to participate in the required assessments
  • Severely impaired memory retention (Score lower than 3 in the 3 Word Delayed Recall test, routinely administered during acute rehabilitation stay
  • Diagnosis of depression. Active substance abuse

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Traumatic brain injury

This trial is currently available in United States.

  • Shirley Ryan AbilityLabChicago, United StatesContact: Katy Magee, M.H.S. SLPTaking people

About the trial

What the trial wants to find out

The purpose of this study is to examine the feasibility and preliminary efficacy of using transcutaneous auricular vagus nerve stimulation (tVNS) to enhance cognitive recovery in patients with mild-moderate traumatic brain injury (TBI).

The 2 groups in the trial

  • Transcutaneous auricular vagus nerve stimulationExisting treatment, for comparison

    Active vagus nerve stimulation.

    Treatment: Transcutaneous auricular vagus active nerve stimulation

  • Sham Transcutaneous auricular vagus nerve stimulationSham treatment, for comparison

    Sham vagus nerve stimulation.

    Treatment: Transcutaneous auricular vagus sham nerve stimulation

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Enhancing Cognitive Rehabilitation After TBI Using Noninvasive Vagal Nerve Stimulation
Criteria questions
Built from NCT06589362, who can take part
Record updated
25 March 2025